This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don’t share our data with other parties. Read more about our cookie policy

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Read more about our cookie policy

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

About the NKI

The Netherlands Cancer Institute was established on October 10, 1913. The founders, Rotgans, professor of Surgery, De Bussy, publisher, and De Vries, professor of Pathology, wanted to create a cancer institute 'where patients suffering from malignant growths could be treated adequately and where cancer and related diseases could be studied'. They bought a house on one of the canals in Amsterdam and named it the 'Antoni van Leeuwenhoek Huis', after the famous Dutch microscopist. The clinic had room for 17 patients, while the laboratory could accommodate 8 to 10 scientists.

Nowadays, The Netherlands Cancer Institute accommodates approximately 650 scientists and scientific support personnel. The Antoni van Leeuwenhoek Hospital has 185 medical specialists, 180 beds, an out-patients clinic with around 106,000 visits, 12 operating theaters and 11 irradiotion units for radiotherapy. It is the only dedicated cancer center in The Netherlands and maintains an important role as a national and international center of scientific and clinical expertise, development and training.


  • 22Jun 2017

    Cancer risk BRCA mutation carriers specified

    A large international study among women with a BRCA mutation in their DNA demonstrates how high their risk is of developing breast cancer. Roughly 3 out of 4 women with a BRCA1 or BRCA2 mutation end up having breast cancer by the age of 80.

    Read More
  • 13Jun 2017

    Extensive lymph node removal not necessary for melanoma patients

    A large clinical phase 3 study shows that immediate removal of all regional lymph nodes from patients with melanoma and metastases in the sentinel node does not improve their melanoma specific survival.

    Read More
  • 09Jun 2017

    New method uncovers complex cellular signal routes

    Researchers of the Netherlands Cancer Institute developed a method for studying communication routes in the cell. With a combination of DNA sequencing and antibodies they can now map the genetic regulators of virtually any human protein.

    Read More
  • 06Jun 2017

    Chance of survival from ovarian cancer greater with chemo lavage of the abdominal cavity

    In women with metastasized ovarian cancer in the abdominal cavity but not beyond (stage III), it appears that chemo lavage with heated chemotherapy - hyperthermic intraperitoneal chemotherapy, HIPEC - improves the survival rate by 10%.

    Read More

Board of Directors

Overview boards and commissions


Internal procedures

The NKI has adopted several regulations and procedures which help us organize our research along national and international standards. The most important regulations and procedures can be found here.

Read more


Technology Transfer Office

The NKI has a mission to beat cancer and performs world-beating research to increase our understanding of this disease. The knowledge that is gained in this way sometimes opens avenues for development of e.g. novel treatments or new diagnostic tests. To achieve its mission, NKI actively collaborates with private companies that have the knowledge and the means to develop products based on research results obtained at our institution.

Go to the site of the Technology Transfer Office

Scientific Annual Reports (SAR)



Group Leaders51
PhD Students187


  • Silhoutten



  • Silhoutten



  • Horloge



  • Silhoutten



  • Bed



Key Figures Research

Publications in 2014 542
Total impact of publications in 2014 3712
Avarage impact of publications 2014 6.8

Key Figures Research

Number of divisions 15
Number of Reseach groups 51
Share this page